Colorectal cancer trials recruiting in Rhode Island

All Colorectal cancer trials nationally

Cities in Rhode Island

Recruiting trials in Rhode Island

• A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
  NCT06362369 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Rhode Island: Providence
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
  NCT05334069 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · Rhode Island: Providence, Warwick
• Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
  NCT05174169 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Rhode Island: Providence, Westerly
• Efficacy and Safety of the CG-100 Intraluminal Bypass Device
  NCT04184973 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 70 Years · Sex: All (male and female) · Rhode Island: Providence
• Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
  NCT05080673 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 70 Years · Sex: All (male and female) · Rhode Island: Providence
• Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
  NCT07228832 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Rhode Island: Providence
• SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
  NCT03452774 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Rhode Island: Providence
• Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
  NCT04429542 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Rhode Island: Providence
• Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
  NCT05630794 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Rhode Island: Providence
• Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
  NCT06555133 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Rhode Island: Providence